The Drug Discovery Programme (DDP) has been funded by Cancer Research UK and headed by Martin Drysdale. Our goal is to establish an integrated, industry-standard drug discovery programme to translate basic biology research from the Beatson and other CRUK centres into medicines for the treatment of cancer.
The Beatson Institute’s Research Facilities, which are overseen by Sue Fowler, support all members of the Institute and can also be accessed by other Cancer Research UK-funded scientists within Glasgow, particularly our colleagues within the Institute of Cancer Sciences.
Principal Disease Indication(s)
Fragments, Genome-wide human and mouse RNAi, drug repurposing
NMR/SPR, HCI, MPA, HTS plate reader
Cancer Research UK
Number of Screens / year (any size):
Medicinal Chemistry Follow-up:
Phone: +44 141 330 8001